Premium
Cellular Effects of a New Farnesyltransferase Inhibitor, RPR‐115135, in a Human Isogenic Colon Cancer Cell Line Model System HCT‐116
Author(s) -
RUSSO P.,
OTTOBONI C.,
FALUGI C.,
REINHOLD W.,
RIOU J. F.,
PARODI S.,
O'CONNOR P. M.
Publication year - 1999
Publication title -
annals of the new york academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.712
H-Index - 248
eISSN - 1749-6632
pISSN - 0077-8923
DOI - 10.1111/j.1749-6632.1999.tb09429.x
Subject(s) - cancer , clinical oncology , medicine , farnesyltransferase , colorectal cancer , cancer treatment , library science , oncology , gerontology , chemistry , computer science , prenylation , biochemistry , enzyme